Coral Gables, FL / ACCESSWIRE / October 31, 2014 / ViaDerma, Inc. (OTCQB: VDRM) ecently released a revolutionary new wound care drug called TetraStem. TetraStem is a topical liquid tetracycline-based antibiotic that uses a patent-pending innovative transdermal delivery system that can convert oral medication active ingredients into topical drugs. The drug is FDA registered as a first aid antibiotic to help prevent skin infection in minor cuts, scrapes, and burns, but has also shown to be effective in fighting methicillin-resistant Staphyloccus aureus (MRSA) infections.
ViaDerma, Inc. is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. ViaDerma's lead product, TetraStem, uses an innovative transdermal delivery method to apply almost any active ingredient to a topical drug. This patent-pending dual carrier transdermal technology may be applied in products within the medical and cosmetic markets.
Find out what could be the best investor's move when it comes to VDRM by getting the complete report here or by cutting and pasting the following link in your Web browser: http://dailystockreporter.com/market-scan/?symbol=vdrm
Terra Tech Corp (OTCQB: TRTC) announced that they have received a unanimous vote for approval of their Western Avenue dispensary location by the Las Vegas City Council. On October 29, 2014, the City Council voted to approve both the MediFarm SUP and the Compliance Permit. If MediFarm receives a State provisional registration certificate for a Medical Marijuana Dispensary at this location on November 3, 2014, then MediFarm will proceed with the last step for full licensure, a final review for a privileged business license in the City of Las Vegas. If succesful the company will begin construction at their Western Ave location and will open under the name Blum LV.MediFarm, LLC, a subsidiary of Terra Tech Corp., originally submitted its applications to the City of Las Vegas on July 23, 2014, to obtain a Special Use Permit (SUP) and Compliance Permit for a Medical Marijuana Dispensary to be located at 1921 Western Avenue in Las Vegas, Nevada. Issuance of the SUP demonstrates compliance with land use requirements and issuance of the Compliance Permit is required prior to the City issuing a business license. The Downtown Design Review Committee approved the building elevations and signage for MediFarm's dispensary at this location on August 26, 2014 and the City Planning Commission voted to recommend approval of the SUP on September 30, 2014. The City of Las Vegas Planning Department recommended approval of MediFarm's Compliance Permit with approval of the SUP.
Terra Tech Corp. through its wholly-owned subsidiary GrowOp Technology, specializes in controlled environment agricultural technologies. The company integrates best-of-breed hydroponic equipment with proprietary software and hardware to provide sustainable solutions for indoor agriculture enterprises and home practitioners. Our complete product line is available at specialty retailers throughout the United States, and via our website. Through its wholly-owned subsidiary Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as Shoprite, Food Emporium and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, and Pennsylvania. MediFarm LLC is focused on securing permits to operate medical cannabis businesses in Nevada.
Find out what could be the best investor's move when it comes to TRTC by getting the complete report here or by cutting and pasting the following link in your Web browser: http://dailystockreporter.com/market-scan/?symbol=trtc
Millennium Healthcare Inc. (OTCQB: MHCC) announced that revenues for the three months ended September 30, 2014 are expected to be in excess of $6.0 million. This represents significant growth compared with revenue of $490,000 for the comparable 2013 period, and was largely the result of the initial roll out of the Company's medical device distribution model. During the quarter Millennium Healthcare began the commercial introduction of its first two distributed medical device products, namely VasoScan(TM), a cardiovascular diagnostic assessment test, and OralCDx(TM), a non-invasive brush biopsy kit for oral cancer. Millennium intends to continue its model and mission of evaluating early detection and diagnostic devices and continually looks to add and provide additional products to its medical device lines available for distribution.
Millennium Healthcare Inc., through its wholly owned operating subsidiaries, provides primary care physician practices, physician groups and healthcare facilities of all sizes with cutting-edge medical devices focused primarily on preventive care through early detection. The Company also provides advanced billing and coding services, and practice development and management services.
Find out what could be the best investor's move when it comes to MHCC by getting the complete report here or by cutting and pasting the following link in your Web browser: http://dailystockreporter.com/market-scan/?symbol=mhcc
ABOUT US:
www.DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Subscribe to the www.DailyStockReporter.com newsletter and start receiving daily alerts.
Subscribe Here: http://www.DailyStockReporter.com/
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. EGM FIRM INC which owns www.DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. EGM FIRM INC which owns www.DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. EGM FIRM INC which owns www.DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
CONTACT:
Company: EGM FIRM INC.
Contact Name: Adam Heimann
Contact Email: [email protected]
SOURCE: Pennystockhub.com